Rivaroxaban combined with spironolactone attenuates cardiovascular remodeling due to hypoxia in pulmonary arterial hypertension

被引：0
|
作者：
Hayashi, T. [1 ]
Matsumoto, S. [1 ]
Hosokawa, A. [1 ]
Yamamoto, K. [1 ]
Nomura, A. [1 ]
Woo, E. [2 ]
Imano, H. [1 ]
Kato, R. [1 ]
Ijiri, Y. [1 ]
Yamaguchi, T. [3 ]
Izumi, Y. [3 ]
Yoshiyama, M. [3 ]
Okada, Y. [2 ]
Asahi, M. [2 ]
机构：
[1] Osaka Univ Pharmaceut Sci, Takatsuki, Osaka, Japan
[2] Osaka Med Coll, Takatsuki, Osaka, Japan
[3] Osaka City Univ, Osaka, Japan
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2501
引用
收藏
页码：485 / 485
页数：1
相关论文
共 50 条
  • [31] Formononetin attenuates monocrotaline-induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats
    Cai, Changhong
    Xiang, Yijia
    Wu, Yonghui
    Zhu, Ning
    Zhao, Huan
    Xu, Jian
    Lin, Wensheng
    Zeng, Chunlai
    MOLECULAR MEDICINE REPORTS, 2019, 20 (06) : 4984 - 4992
  • [32] Celastrol attenuates the remodeling of pulmonary vascular and right ventricular in monocrotaline-induced pulmonary arterial hypertension in rats
    Li, Huayang
    Liu, Quan
    Yue, Yuan
    Wang, Shunjun
    Huang, Suiqing
    Huang, Lin
    Luo, Li
    Zhang, Yitao
    Wu, Zhongkai
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2022, 12 (01) : 88 - 102
  • [33] Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats
    Zhu, Ning
    Zhao, Xuyong
    Xiang, Yijia
    Ye, Shiyong
    Huang, Jie
    Hu, Wuming
    Lv, Linchun
    Zeng, Chunlai
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 221 : 587 - 596
  • [34] Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats
    Shi, Ruizan
    Wei, Zehui
    Zhu, Diying
    Fu, Naijie
    Wang, Chang
    Yin, Sha
    Liang, Yueqin
    Xing, Jianfeng
    Wang, Xuening
    Wang, Yan
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 : 124 - 135
  • [35] Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
    Mario Boehm
    Nadine Arnold
    Adam Braithwaite
    Josephine Pickworth
    Changwu Lu
    Tatyana Novoyatleva
    David G. Kiely
    Friedrich Grimminger
    Hossein A. Ghofrani
    Norbert Weissmann
    Werner Seeger
    Allan Lawrie
    Ralph T. Schermuly
    Baktybek Kojonazarov
    BMC Pulmonary Medicine, 22
  • [36] PULMONARY HYPERTENSION DUE TO PULMONARY ARTERIAL COARCTATION
    FALKENBACH, KH
    ZHEUTLIN, N
    DOWDY, AH
    OLOUGHLIN, BJ
    RADIOLOGY, 1959, 73 (04) : 575 - 590
  • [37] Effects Of Spironolactone In Pulmonary Arterial Hypertension: Results Of Spiro Study
    Safdar, Z.
    Tamez, E.
    Thakur, A.
    Entman, M.
    Basant, A.
    Frost, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [38] Endogenous Estrogen Attenuates Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Vasoconstriction and Pulmonary Arterial Smooth Muscle Cells Proliferation
    Xu, Dunquan
    Niu, Wen
    Luo, Ying
    Zhang, Bo
    Liu, Manling
    Dong, Haiying
    Liu, Yi
    Li, Zhichao
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (06): : 771 - 781
  • [39] Reversible or Irreversible Remodeling in Pulmonary Arterial Hypertension
    Sakao, Seiichiro
    Tatsumi, Koichiro
    Voelkel, Norbert F.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2010, 43 (06) : 629 - 634
  • [40] Targeting Matrix Remodeling in Pulmonary Arterial Hypertension
    Steppan, Jochen
    Wang, Huilei
    Nomura, Yohei
    Melucci, Sean
    Shimoda, Larissa
    Berkowitz, Daniel
    Santhanam, Lakshmi
    ANESTHESIA AND ANALGESIA, 2017, 124 : 173 - 173
12345